AVANT Immunotherapeutics, Inc. discovers and develops innovative vaccines and therapeutics that harness the human immune system to prevent and treat disease. AVANT has three products on the market and three of AVANT's products are in clinical development. AVANT's pipeline includes products for travelers' vaccines and global health needs based on AVANT's oral, rapid-protecting, single-dose and temperature stable vaccine technology.

Contact Information

119 Fourth Avenue
Needham, MA 02494-2725

tel: 781-433-0771
fax: 781-433-0262


Investor Relations



Exchange: NASDAQ
Industry: Diagnostic Substances
Market Cap: $22.3M

The information provided here has been obtained from publicly available sources as well as directly from issuers in some cases. Please see our Disclaimer and Terms of Service for more information.